Results for
"[search-keyword]"
Sponsor content
412 result(s) found, displaying 251 to 260
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PAVTIDE MDI 50/25 fluticasone propionate 50 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PAVTIDE MDI 125/25 fluticasone propionate 125 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PAVTIDE MDI 250/25 fluticasone propionate 250 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BREO ELLIPTA fluticasone furoate 200 microgram / vilanterol (as trifenatate) 25 microgram powder for inhalation.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BREO ELLIPTA fluticasone furoate 100 microgram / vilanterol (as trifenatate) 25 microgram powder for inhalation.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for mepolizumab (rch)
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd